Superior Prima Sukses Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Superior Prima Sukses Tbk. trades at Rp143 (market cap 1.24T, 818.7K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Superior Prima Sukses Tbk. is far larger — about 7.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Superior Prima Sukses Tbk. is more actively traded (818.7K versus 71K). Which is the better fit depends on your goals.
| BLES | OBAT | |
|---|---|---|
Market Cap | 1.24T | 167.37B |
Volume | 818.7K | 71K |
Lot | 8.19K | 710 |
Turnover | 116.14M | 17.51M |
Average Price | 141.86 | 246.63 |
Value | 116.14M | 17.51M |
Indicative Equilibrium Price | 140 | 246 |
Indicative Equilibrium Volume | 1.2K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Superior Prima Sukses Tbk (the Company) was established based on Notarial Deed of Sriwati, S.H., M.Hum., No. 8 dated November 3, 2011. The Company started its operations in April 2013. PT Global Base Universal is the ultimate parent entity of the Company.
Read more on BLES →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →